Nina Kadan-Lottick, MD

Associate Professor of Pediatrics (Hematology / Oncology); Medical Director, HEROS Program

Clinical Interests

  • Brain Neoplasms
  • Hematologic Diseases
  • Leukemia
  • Medical Oncology
  • Thrombocytopenia

Patient Care

Accepts new patients? Yes
Patient Type: Child
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Hematology Program | Pediatric Hematology & Oncology Program | Supportive Oncology Program

Pediatrics: Pediatric Hematology & Oncology: HEROS Survivorship Clinic | Pediatric Specialty Center

Survivorship Clinic

Yale Medical Group

Board Certifications

  • Pediatric Hematology-Oncology AB of Pediatrics (2000)

Clinical Trials

Conditions Study Title
Brain and Nervous System LGG-14C03 A Phase III Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults with Previously Untreated Low Grade Glioma
Bones and Joints, Brain and Nervous System, Kidney, Lymphoid Leukemia, Other Male Genital Exercise Intervention Program: Feasibility Study
Ill-Defined Sites Umbrella Long-Term Follow-Up Protocol (COG ALTE05N1) (CIRB)
Lymphoid Leukemia Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer (COG ALTE07C1) (CIRB)
Unknown Sites Key Adverse Events after Childhood Cancer (COG ALTE03N1)
Ill-Defined Sites The Connecticut HEROS Registry
Lymphoid Leukemia Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (AALL0932) (CIRB)
Soft Tissue Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma (COG AEWS1031)(CIRB)
Brain and Nervous System Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years (COG ACNS0831) (CIRB)
Liver Treatment of Children with All Stages of Hepatoblastoma: A Groupwide, Phase III Study (COG AHEP0731) (CIRB)
Bones and Joints, Brain and Nervous System, Hodgkin's Lymphoma, Kidney, Leukemia, not otherwise specified, Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Male Genital, Soft Tissue Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Network (COG ACCRN07) (CIRB)
Soft Tissue A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol (COG 9902)
Brain and Nervous System Neuroblastoma Biology Studies (COG ANBL00B1) {CIRB}
Ill-Defined Sites Neuropsychological Functioning in Children Treated for Cancer
Unknown Sites Study of Immune System in Patients with Cancer and Blood Disorders
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications
Leukemia, other A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML): A Groupwide Phase III Study ( COG ACCLO933) (CIRB)
Kidney National Wilms Tumor Late Effects Study (POG 9442)
Leukemia, not otherwise specified A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND#73789, NSC#606869) in the Very Hish Risk Stratum (COG AALL1131)(CIRB)
Myeloid and Monocytic Leukemia AAML1031 A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for patients with High Allelic Ratio FLT3/ITD; A Groupwide II/III Study

Edit this profile